Newsletter

Newsletter

In this section, you will find the lastest news about our products 

Oncomedics Group announces its plans for 2024, including the launch of the Oncotarget kit for the study of solid tumors, as well as advances in clinical studies of metastatic colorectal cancer. They also strengthen their market presence by partnering with Genexpath for sarcoma and lymphoma diagnostics, affirming their commitment to innovation and medical advancement.